Merck To Increase Internal R&D But Reduce Outside Deals In 2005
Executive Summary
Merck expects to decrease its spending on product acquisition and licensing deals in 2005, the company told analysts during its Dec. 14 annual business review in Whitehouse Station, N.J
You may also be interested in...
Merck To Sign 50 Business Development Deals In 2005
Merck's goal is to sign about 50 business development deals in 2005, the same level as 2004, the company said
Merck Sales Force More Focused, Not Smaller, After Vioxx Withdrawal
Merck sales reps will detail fewer products to fewer doctors under a reorganized structure, the company told analysts during its investor day Dec. 14
Merck Sales Force More Focused, Not Smaller, After Vioxx Withdrawal
Merck sales reps will detail fewer products to fewer doctors under a reorganized structure, the company told analysts during its investor day Dec. 14